SFN and lung adenocarcinoma: Prof. Masayuki Noguchi’s team identified that SFN specifically binds to ubiquitinated protease 8 (USP8) in lung adenocarcinoma cells, enhancing the stabilization of receptor tyrosine kinases (RTKs), including EGFR and MET, through abnormal regulation of USP8.